Presentation TCT 2013 Upstream Bivalirudin: Insights from EuroMax Presenter: Philippe Gabriel Steg October 30, 2013
Presentation TCT 2013 Intricacies and Difficulties with Using the AUC as a Cath Lab Metric Presenter: Stephen Ramee October 30, 2013
Presentation TCT 2013 Differentiating Functional from Degenerative MR: Importance and Key Findings Presenter: Judy Hung October 30, 2013
Presentation TCT 2013 Evolving Role of the Macrophage in Vulnerable Plaque, and Imaging Methods Presenter: Aloke Finn October 30, 2013
Presentation TCT 2013 The Odyssey of TAVR: From Concept to Clinical Reality Presenter: Alain Cribier October 30, 2013
Presentation TCT 2013 Carotid Stenting Randomized Trials Redux: ACST2, SPACE 2, and CREST2 Presenter: Alison Halliday October 30, 2013
Presentation TCT 2013 MitraClip Patient Selection for FMR II. Identifying Appropriate Patients Presenter: Anita Asgar October 30, 2013
Presentation TCT 2013 Hybrid Strategies for Treatment of Aortic Arch Pathologies Presenter: Wilson Szeto October 30, 2013
Presentation TCT 2013 Case Presentation: Paravalvular AR After TAVR Presenter: Femi Philip October 30, 2013
Presentation TCT 2013 The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? No! A Futile, Expensive, and Risky Enterprise! Presenter: John Ambrose October 30, 2013